Search

Author/Creator Koehler, Amber B.

1. Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare. Issue 3 (13th December 2019)

Authors:
Hampel, Paul J.; Call, Timothy G.; Ding, Wei; Muchtar, Eli; Kenderian, Saad S.; Wang, Yucai; Leis, Jose F.; Witzig, Thomas E.; Koehler, Amber B.; Fonder, Amie L.; Schwager, Susan M.; Rabe, Kari G.; Van Dyke, Daniel L.; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
American journal of hematology
Issue:
Volume 95:Issue 3(2020:Mar.)
Page Start:
E57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia. (16th July 2022)

Authors:
Hampel, Paul J.; Rabe, Kari G.; Call, Timothy G.; Ding, Wei; Leis, Jose F.; Kenderian, Saad S.; Muchtar, Eli; Wang, Yucai; Koehler, Amber B.; Parrondo, Ricardo; Schwager, Susan M.; Shi, Min; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
British journal of haematology
Issue:
Volume 199:Number 2(2022)
Page Start:
239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia. (20th September 2020)

Authors:
Hampel, Paul J.; Call, Timothy G.; Rabe, Kari G.; Ding, Wei; Muchtar, Eli; Kenderian, Saad S.; Wang, Yucai; Leis, Jose F.; Witzig, Thomas E.; Koehler, Amber B.; Fonder, Amie L.; Schwager, Susan M.; Van Dyke, Daniel L.; Braggio, Esteban; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
Oncologist
Issue:
Volume 25:Number 11(2020)
Page Start:
974
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. DTRMWXHS‐12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open‐label, multicenter, phase 1a/1b study. Issue 5 (7th March 2023)

Authors:
Huntington, Scott F.; Schuster, Stephen J.; Ding, Wei; Koehler, Amber B.; Brander, Danielle M.; Rosenthal, Allison C.; Leis, Jose F.; Tun, Han W.; Moustafa, Muhamad Alhaj; Iqbal, Madiha; He, Wei; Kearney, Albert S.; McKinlay, Timothy P.; Gui, Min; Mato, Anthony R.
Journal:
American journal of hematology
Issue:
Volume 98:Issue 5(2023)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis. Issue 1 (5th November 2021)

Authors:
Muchtar, Eli; Koehler, Amber B.; Johnson, Michael J.; Rabe, Kari G.; Ding, Wei; Call, Timothy G.; Leis, Jose F.; Kenderian, Saad S.; Hayman, Suzanne R.; Wang, Yucai; Hampel, Paul J.; Holets, Matthew A.; Darby, Heather C.; Slager, Susan L.; Kay, Neil E.; Miao, Congrong; Canniff, Jennifer; Whitaker...
Journal:
American journal of hematology
Issue:
Volume 97:Issue 1(2022)
Page Start:
90
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice. Issue 10 (23rd August 2020)

Authors:
Koehler, Amber B.; Leung, Nelson; Call, Timothy G.; Rabe, Kari G.; Achenbach, Sara J.; Ding, Wei; Kenderian, Saad S.; Leis, Jose F.; Wang, Yucai; Muchtar, Eli; Hayman, Suzanne R.; Hampel, Paul J.; Finnes, Heidi D.; Schwager, Susan M.; Slager, Susan L.; Kay, Neil E.; Parikh, Sameer A.
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 10(2020)
Page Start:
2383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice. Issue 11 (19th September 2019)

Authors:
Hampel, Paul J.; Ding, Wei; Call, Timothy G.; Rabe, Kari G.; Kenderian, Saad S.; Witzig, Thomas E.; Muchtar, Eli; Leis, Jose F.; Chanan-Khan, Asher A.; Koehler, Amber B.; Fonder, Amie L.; Schwager, Susan M.; Slager, Susan L.; Shanafelt, Tait D.; Kay, Neil E.; Parikh, Sameer A.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 11(2019)
Page Start:
2712
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice. (18th March 2020)

Authors:
Parikh, Sameer A.; Achenbach, Sara J.; Call, Timothy G.; Rabe, Kari G.; Ding, Wei; Leis, Jose F.; Kenderian, Saad S.; Chanan‐Khan, Asher A.; Koehler, Amber B.; Schwager, Susan M.; Muchtar, Eli; Fonder, Amie L.; McCullough, Kristen B.; Nedved, Adrienne N.; Smith, Matthew D.; Slager, Susan L.; Kay,...
Journal:
Cancer medicine
Issue:
Volume 9:Number 10(2020)
Page Start:
3390
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. The prognostic significance of del6q23 in chronic lymphocytic leukemia. Issue 6 (7th April 2021)

Authors:
Audil, Hadiyah Y.; Hampel, Paul J.; Van Dyke, Daniel L.; Achenbach, Sara J.; Rabe, Kari G.; Smoley, Stephanie A.; Call, Timothy G.; Ding, Wei; Shi, Min; Hanson, Curtis A.; Wang, Yucai; Muchtar, Eli; Koehler, Amber B.; Schwager, Susan M.; Leis, Jose F.; Braggio, Esteban; Slager, Susan L.; Kay, Nei...
Journal:
American journal of hematology
Issue:
Volume 96:Issue 6(2021)
Page Start:
E203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗